InspireMD, Inc.
(NYSE Amex Equities : NSPR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. -0.16%25.5810.1%$1544.19m
TMOThermo Fisher Scientific, Inc. 1.79%385.721.0%$548.16m
MDTMedtronic Plc 1.35%94.030.6%$528.03m
BDXBecton, Dickinson & Co. 1.60%261.521.0%$489.57m
DXCMDexCom, Inc. -0.03%404.138.2%$486.23m
ABTAbbott Laboratories 1.94%94.530.8%$483.87m
DHRDanaher Corp. 1.38%184.930.7%$433.11m
BSXBoston Scientific Corp. 1.76%35.051.0%$420.98m
QDELQuidel Corp. 1.52%238.067.7%$399.13m
ISRGIntuitive Surgical, Inc. 1.99%582.662.4%$325.12m
SYKStryker Corp. 2.40%182.131.3%$307.88m
BAXBaxter International, Inc. 0.91%84.221.8%$261.80m
ALGNAlign Technology, Inc. 10.36%298.236.3%$223.75m
ZBHZimmer Biomet Holdings, Inc. 2.23%123.571.7%$208.65m
BIOBio-Rad Laboratories, Inc. 3.56%484.582.9%$206.15m

Company Profile

InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.